JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.65% |
| 2 | Technology | 15.75% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3926
Northrim BanCorp
NRIM
$547M
| $1.25M | ﹤0.01% |
117,960
-12,676
| -10% | -$122K |
2017 Q4
13 quarters
|
|
3927
Mirion Technologies
MIR
$3.59B
| $1.25M | ﹤0.01% |
120,000
-62,580
| -34% | -$735K |
2020 Q4
1 quarter
|
|
3928
CALL
FedEx
FDX
$68.3B
| $1.25M | ﹤0.01% |
4,400
-16,000
| -78% | -$4.12M |
2020 Q4
1 quarter
|
|
3929
MVB Financial
MVBF
$395M
| $1.25M | ﹤0.01% |
36,970
+6,425
| +21% | +$180K |
2018 Q2
11 quarters
|
|
3930
Hingham Institution for Saving
HIFS
$628M
| $1.25M | ﹤0.01% |
4,398
+244
| +6% | +$61K |
2016 Q3
18 quarters
|
|
3931
Carriage Services
CSV
$496M
| $1.25M | ﹤0.01% |
35,452
+4,207
| +13% | +$146K |
2015 Q4
21 quarters
|
|
3932
Community Health Systems
CYH
$386M
| $1.24M | ﹤0.01% |
91,882
+18,109
| +25% | +$178K |
2013 Q2
31 quarters
|
|
3933
KB Financial Group
KB
$43B
| $1.24M | ﹤0.01% |
25,145
+17,301
| +221% | +$720K |
2013 Q3
30 quarters
|
|
3934
Capital City Bank Group
CCBG
$843M
| $1.24M | ﹤0.01% |
47,650
+871
| +2% | +$22.1K |
2016 Q4
17 quarters
|
|
3935
Tredegar Corp
TG
$245M
| $1.24M | ﹤0.01% |
82,519
+22,844
| +38% | +$366K |
2013 Q2
31 quarters
|
|
3936
ARS Pharmaceuticals
SPRY
$419M
| $1.24M | ﹤0.01% |
+28,350
| New | +$1.34M |
2021 Q1
0 quarters
|
|
3937
Lifecore Biomedical
LFCR
$248M
| $1.24M | ﹤0.01% |
116,562
+42,633
| +58% | +$479K |
2017 Q4
13 quarters
|
|
3938
Rafael Holdings
RFL
$77.5M
| $1.24M | ﹤0.01% |
31,406
+7,596
| +32% | +$246K |
2018 Q1
12 quarters
|
|
3939
Rocket Lab Corp
RKLB
$47.2B
| $1.24M | ﹤0.01% |
+104,271
| New | +$1.16M |
2021 Q1
0 quarters
|
|
3940
Organogenesis Holdings
ORGO
$175M
| $1.23M | ﹤0.01% |
67,711
+4,985
| +8% | +$67.5K |
2019 Q1
8 quarters
|
|
3941
Napco Security Technologies
NSSC
$1.3B
| $1.23M | ﹤0.01% |
70,458
-4,120
| -6% | -$63.6K |
2017 Q4
13 quarters
|
|
3942
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.33B
| $1.23M | ﹤0.01% |
12,026
-30,376
| -72% | -$3.1M |
2019 Q4
5 quarters
|
|
3943
Phibro Animal Health
PAHC
$1.49B
| $1.23M | ﹤0.01% |
50,217
-6,633
| -12% | -$150K |
2014 Q2
27 quarters
|
|
|
RDS.B
3944
PUT
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.22M | ﹤0.01% |
+33,200
| New | +$1.27M |
2021 Q1
0 quarters
|
|
|
BPYU
3945
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $1.22M | ﹤0.01% |
68,096
+45,202
| +197% | +$801K |
2018 Q3
10 quarters
|
|
3946
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.75B
| $1.22M | ﹤0.01% |
13,844
-19,562
| -59% | -$1.65M |
2018 Q4
9 quarters
|
|
|
CLVS
3947
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.22M | ﹤0.01% |
173,891
-43,246
| -20% | -$290K |
2013 Q2
31 quarters
|
|
|
MMP
3948
CALL
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.22M | ﹤0.01% |
+28,100
| New | +$1.23M |
2021 Q1
0 quarters
|
|
3949
CALL
Shopify
SHOP
$196B
| $1.22M | ﹤0.01% |
11,000
-89,000
| -89% | -$10.8M |
2020 Q4
1 quarter
|
|
3950
Viemed Healthcare
VMD
$342M
| $1.22M | ﹤0.01% |
120,329
-86,782
| -42% | -$817K |
2020 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q1 2021, opening 866 new positions and adding to 2,869 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 461 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.